Defina, Marzia <br/><br/>
Evaluation of residual CD34(+) Ph(+)  progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.  [electronic resource] 

 -  Cancer  Nov 2012 
 - 5265-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.27506  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD34--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Cells--pathology<br/>Female<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Leukemia, Myeloid, Chronic-Phase--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplastic Stem Cells--pathology<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use